Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Fournier

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Gene therapy, cell transplantation and strokeCesario V Borlongan, Christina Fournier, Christine E Stahl, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 2, 2025
Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium datasetDavid Schneck, Andres Arguedas, Annette Xenopoulos-Oddsson, et al.
Human Molecular Genetics|April 16, 2019
Rare variants in MYH15 modify amyotrophic lateral sclerosis riskHyerim Kim, Junghwa Lim, Han Bao, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 14, 2025
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium datasetAndres Arguedas, David Schneck, Erjia Cui, et al.
Nature|October 1, 2025
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosisTanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, et al.
Neurology|July 1, 2016
Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsJonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, et al.
Nature|March 19, 2026
Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosisTanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trialsAngela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Gene therapy, cell transplantation and strokeCesario V Borlongan, Christina Fournier, Christine E Stahl, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 2, 2025
Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium datasetDavid Schneck, Andres Arguedas, Annette Xenopoulos-Oddsson, et al.
Human Molecular Genetics|April 16, 2019
Rare variants in MYH15 modify amyotrophic lateral sclerosis riskHyerim Kim, Junghwa Lim, Han Bao, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 14, 2025
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium datasetAndres Arguedas, David Schneck, Erjia Cui, et al.
Nature|October 1, 2025
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosisTanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, et al.
Neurology|July 1, 2016
Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsJonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, et al.
Nature|March 19, 2026
Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosisTanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trialsAngela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Pageof 3